You win during the SOUL clinic?

This study looks at where colorectal cancer spreads to lymph nodes after surgery. It aims to improve how doctors check lymph nodes to better understand the cancer and guide future treatment.

This trial compares two ways of removing lymph nodes (small glands that help fight infection) during robotic surgery for mid or low rectal cancer. It aims to see whether removing fewer lymph nodes may be just as effective and cause fewer side effects than removing a larger group of them.

This trial tests a program that helps you and your doctor decide together whether to avoid surgery and keep your rectum after chemo and radiation. It's for people with early-stage rectal cancer who have not had prior treatment for this cancer.

This Phase 2 study tests a “total neoadjuvant” approach, meaning you receive cancer treatment before surgery, to improve safety and effectiveness for rectal cancer. It may help by shrinking the tumor and planning a more effective operation, while researchers carefully track side effects.

This trial tests whether some people with locally advanced rectal cancer can safely avoid surgery after chemoradiotherapy. If the tumor disappears, patients may be monitored closely instead of having an operation, which could help preserve the anus.

This trial tests whether removing lymph nodes in the pelvis during laparoscopic surgery for rectal neuroendocrine tumors (a type of slow-growing or aggressive tumor) improves outcomes. It is for people with larger or recurrent tumors, or those at higher risk due to tumor grade or depth.